Hironori Tsujimoto | Medicine and Dentistry | Best Researcher Award

Hironori Tsujimoto | Medicine and Dentistry | Best Researcher Award

Prof Dr Hironori Tsujimoto National Defense Medical College, Japan

Prof. Dr. Hironori Tsujimoto’s education, professional experience, and research publications, he is indeed a strong candidate for the Best Researcher Award. His research in upper-gastrointestinal surgery, oncology, and innovative therapeutic techniques demonstrates significant contributions to the field. Below is a breakdown of his qualifications:

Publiacation Profile

orcid

Educational Background and Professional Experience

Prof. Dr. Tsujimoto graduated from the National Defense Medical College in 1993, completed his residency, and advanced his career through post-doctoral studies at both National Defense Medical College and the University of Florida. Since 2007, he has held key positions, including Assistant Professor and Director of Upper-gastrointestinal Surgery, contributing extensively to both surgical practice and research.

Research Contributions

Prof. Tsujimoto has consistently focused on cancer research, especially in gastrointestinal malignancies, lymph node metastasis, and therapeutic innovations. His research output, including publications in top journals, underscores his influence in the field. Some highlights include the study on high mobility group box chromosomal protein 1 expression in esophageal squamous cell carcinoma, published in Journal of Gastroenterology and Hepatology (2020). This work showed how perioperative protein levels impact long-term outcomes in cancer patients, advancing clinical management practices.

Membership

Prof. Tsujimoto is an active member of several prestigious medical organizations in Japan. These include the Japanese Surgical Society, the Japanese Society of Gastroenterological Surgery, and the Japanese Society for Clinical Surgery. Dr. [Name] also contributes to the Japanese Society for Surgical Metabolism and Nutrition, the Japan Shock Society, and the Japan Society for Endoscopic Surgery. Through these memberships, they stay at the forefront of surgical innovation and patient care, enhancing their expertise and contributing to the medical community.

Research

From 1993 to 2000, I served as a Research Associate at the Department of Surgery I, National Defense Medical College, under the guidance of Professor Mochizuki H. Since 2000, I have continued as a Research Associate at the same institution, now working in the Department of Surgery alongside Professor Hase K., with additional supervision by Professor Seki S. from the Department of Immunology and Microbiology. My research spans over two decades, contributing to advancements in surgical and immunological fields.

Publication Top Notes

Significance of resected stomach measurements in postoperative delayed gastric emptying following laparoscopic pylorus‐preserving gastrectom

ASO Author Reflections: Development and Validation Study of the Prognostic Impact of Deep Learning-Determined Myxoid Stroma After Neoadjuvant Chemotherapy in Patients with Esophageal Squamous Cell Carcinoma

Pivotal role of myeloid‐derived suppressor cells in infection‐related tumor growth

Postoperative complications and impaired long‐term survival—Is this causation or association?

Bacterial Translocation in Gastrointestinal Cancers and Cancer Treatment

Conclusion

Prof. Dr. Hironori Tsujimoto’s contributions to surgical oncology and innovative cancer treatments underscore his suitability for the Best Researcher Award. His pioneering work on photodynamic therapy, novel surgical techniques, and understanding of cancer progression significantly advances gastrointestinal surgery and cancer care.

Erica Pietroluongo | Medicine | Young Scientist Award

Dr. Erica Pietroluongo | Medicine | Young Scientist Award

Dr. Erica Pietroluongo, University of Naples Federico II, Italy

👩‍⚕️ Dr. Erica Pietroluongo is a dedicated oncologist and researcher based in Naples, Italy. With an MD from the University of Naples Federico II and ongoing PhD studies in Advanced Biomedical and Surgical Therapies, she specializes in medical oncology, particularly in rare tumors. Dr. Pietroluongo is actively involved in various professional societies, including the American Society of Clinical Oncology and the International Thymic Malignancy Working Group. Her research focuses on improving treatment personalization in breast cancer and investigating bioumoral determinants in SARS-Cov-2-infected patients with thymic epithelial tumors. She also contributes to teaching and training future medical professionals.

Publication Profile:

Scopus

Orcid

Education:

📚 Dr. Erica Pietroluongo pursued her passion for medicine at the University of Naples Federico II, where she earned her MD in Medicine. With a strong foundation in healthcare, she embarked on a journey of continuous learning, currently immersing herself in the realm of research as a PhD student in Advanced Biomedical and Surgical Therapies. Under the guidance of Prof. F Pane at the Department of Clinical Medicine and Surgery, University of Naples Federico II, she delves into cutting-edge studies. 🎓 Committed to advancing medical knowledge, Dr. Pietroluongo’s dual roles as a physician and researcher epitomize her dedication to enhancing patient care and outcomes.

Teaching and Training:

📝 Dr. Erica Pietroluongo is deeply committed to advancing her skills in clinical research and teaching methodologies. In April 2023, she participated in a Medical Writing Course organized by the Italian Society of Surgery in Campobasso, in collaboration with prestigious institutions like Springer Nature and the University of Naples Federico II. This course equipped her with essential writing skills vital for disseminating research findings effectively. Moreover, in June 2023, she further honed her expertise as an “Expert in Evaluation and Facilitation of Regional Oncology Networks” through a program facilitated by AGENAS, the National Agency for Health Regional Services. 🌟 These training initiatives underscore Dr. Pietroluongo’s commitment to enhancing her capabilities and contributing to the advancement of healthcare practices.

Research Focus:

🔍 Dr. Erica Pietroluongo’s research focus primarily revolves around two key areas: thymic epithelial tumors and breast cancer. In her studies on thymic epithelial tumors, she explores the impact of SARS-Cov-2 mRNA vaccines on patients’ immune responses and seroconversion. Additionally, she investigates the potential diagnostic role of miRNAs in breast cancer, particularly miRNA-27a and miRNA-128, packaged in extracellular vesicles. Her work not only sheds light on the immunological responses to COVID-19 vaccines in cancer patients but also aims to identify novel biomarkers for improved diagnosis and prognosis in breast cancer. Dr. Pietroluongo’s research contributes significantly to both oncology and immunology fields. 🎯

Publication Top Notes: